Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042)

Weber, Damien C; Ares Molina, Carmen; Villa, Salvador; Peerdeman, Saskia M; Renard, Laurette; Baumert, Brigitta G; Lucas, Anna; Veninga, Theo; Pica, Alessia; Jefferies, Sarah; Ricardi, Umberto; Miralbell, Raymond; Stelmes, Jean-Jacques; Liu, Yan; Collette, Laurence; Collette, Sandra

doi:10.1016/j.radonc.2018.06.018

Scientific article

English

Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042)

ContributorsWeber, Damien C; Ares Molina, Carmen; Villa, Salvador; Peerdeman, Saskia M; Renard, Laurette; Baumert, Brigitta G; Lucas, Anna; Veninga, Theo; Pica, Alessia; Jefferies, Sarah; Ricardi, Umberto; Miralbell, Raymond; Stelmes, Jean-Jacques; Liu, Yan; Collette, Laurence; Collette, Sandra

Published inRadiotherapy and Oncology, vol. 128, no. 2, p. 260-265

Publication date2018

Abstract

The therapeutic strategy for non-benign meningiomas is controversial. The objective of this study was to prospectively investigate the impact of high dose radiation therapy (RT) on the progression-free survival (PFS) rate at 3 years in WHO grade II and III meningioma patients.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de radiologie et informatique médicale

Research groups

Groupe Miralbell Raymond (radio-oncologie) (685)

Citation (ISO format)

WEBER, Damien C et al. Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042). In: Radiotherapy and Oncology, 2018, vol. 128, n° 2, p. 260–265. doi: 10.1016/j.radonc.2018.06.018

Article (Published version)

Identifiers

PID : unige:111083
DOI : 10.1016/j.radonc.2018.06.018
PMID : 29960684

Journal ISSN0167-8140

494views

2106downloads

Creation13/09/2018 16:24:00

First validation13/09/2018 16:24:00

Update15/03/2023 13:51:21

Status update15/03/2023 13:51:20

Last indexation31/10/2024 11:49:54

Archive ouverte UNIGE

Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042)

The therapeutic strategy for non-benign meningiomas is controversial. The objective of this study was to prospectively investigate the impact of high dose radiation therapy (RT) on the progression-free survival (PFS) rate at 3 years in WHO grade II and III meningioma patients.

Technical informations

The therapeutic strategy for non-benign meningiomas is controversial. The objective of this study was to prospectively investigate the impact of high dose radiation therapy (RT) on the progression-free survival (PFS) rate at 3 years in WHO grade II and III meningioma patients.